We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VistaGen Therapeutics Provides Investor Update on Corporate Activities and Upcoming Initiatives

News   Sep 16, 2011

 
VistaGen Therapeutics Provides Investor Update on Corporate Activities and Upcoming Initiatives
 
 
 

RELATED ARTICLES

Temperature-stable Tuberculosis Vaccine Enters Clinical Testing

News

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

READ MORE

Stem Cells Grown in Media Free of Animal-derived Compounds

News

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

READ MORE

Cultivating 4D Tissues – the First Self-curving Cornea

News

Scientists have developed a biological system which lets cells form a desired shape by moulding their surrounding material - initially creating the world's first self-curving cornea.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE